Quantum-Si Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
145
- Stock Symbol
-
QSI
- Investments
-
2
- Share Price
-
$0.91
- (As of Friday Closing)
Quantum-Si General Information
Description
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
Contact Information
Website
www.quantum-si.comCorporate Office
- 29 Business Park Drive
- Unit Suite C
- Branford, CT 06405
- United States
Corporate Office
- 29 Business Park Drive
- Unit Suite C
- Branford, CT 06405
- United States
Quantum-Si Stock Performance
As of 20-Nov-2026, Quantum-Si’s stock price is $0.91. Its current market cap is $200M with 220M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.91 | $1.07 | $0.69 - $1.81 | $200M | 220M | 6.87M | -$0.39 |
Quantum-Si Financials Summary
As of 30-Sep-2026, Quantum-Si has a trailing 12-month revenue of $1.26M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 125,718 | 15,805 | 202,806 | 25,699 |
| Revenue | 1,265 | 2,436 | 3,058 | 1,082 |
| EBITDA | (87,159) | (105,791) | (105,989) | (92,263) |
| Net Income | (85,132) | (101,339) | (101,007) | (95,960) |
| Total Assets | 172,887 | 245,607 | 247,871 | 298,250 |
| Total Debt | 2,777 | 4,166 | 12,948 | 15,303 |
Quantum-Si Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quantum-Si Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Quantum-Si Comparisons
Industry
Financing
Details
Quantum-Si Competitors (5)
One of Quantum-Si’s 5 competitors is Nautilus Biotechnology, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nautilus Biotechnology | Formerly VC-backed | Seattle, WA | ||||
| Seer | Formerly VC-backed | Redwood City, CA | ||||
| Olink Proteomics | Formerly PE-Backed | Uppsala, Sweden | ||||
| SomaLogic Operating Company | Formerly PE-Backed | Boulder, CO | ||||
| Illumina | Formerly VC-backed | San Diego, CA |
Quantum-Si Patents
Quantum-Si Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260171192-A1 | Techniques for detecting amino acid variants using next-generation protein sequencing | Pending | 17-Dec-2024 | ||
| WO-2026136555-A1 | Techniques for detecting amino acid variants using next-generation protein sequencing | Pending | 17-Dec-2024 | ||
| WO-2026117728-A1 | Improved library preparation for polypeptide sequencing | Pending | 27-Nov-2024 | ||
| US-20260140120-A1 | Spatially-multiplexed fluorescence imaging | Pending | 19-Nov-2024 | ||
| WO-2026112053-A1 | Spatially-multiplexed fluorescence imaging | Pending | 19-Nov-2024 | G01N33/6818 |
Quantum-Si Signals
Quantum-Si Acquisitions (2)
Quantum-Si’s most recent deal was a Merger/Acquisition with Majelac Technolgies for . The deal was made on 05-Nov-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Majelac Technolgies | 05-Nov-2021 | Merger/Acquisition | Other Containers and Packaging | ||
| HighCape Capital Acquisition | 10-Jun-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Quantum-Si ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
21.6 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Quantum-Si FAQs
-
When was Quantum-Si founded?
Quantum-Si was founded in 2013.
-
Where is Quantum-Si headquartered?
Quantum-Si is headquartered in Branford, CT.
-
What is the size of Quantum-Si?
Quantum-Si has 145 total employees.
-
What industry is Quantum-Si in?
Quantum-Si’s primary industry is Discovery Tools (Healthcare).
-
Is Quantum-Si a private or public company?
Quantum-Si is a Public company.
-
What is Quantum-Si’s stock symbol?
The ticker symbol for Quantum-Si is QSI.
-
What is the current stock price of Quantum-Si?
As of 20-Nov-2026 the stock price of Quantum-Si is $0.91.
-
What is the current market cap of Quantum-Si?
The current market capitalization of Quantum-Si is $200M.
-
What is Quantum-Si’s current revenue?
The trailing twelve month revenue for Quantum-Si is $1.26M.
-
Who are Quantum-Si’s competitors?
Nautilus Biotechnology, Seer, Olink Proteomics, SomaLogic Operating Company, and Illumina are competitors of Quantum-Si.
-
What is Quantum-Si’s annual earnings per share (EPS)?
Quantum-Si’s EPS for 12 months was -$0.39.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process